LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 1,334.10%2.14B | -110.63%-173M | -35.11%1.63B | 38.39%2.51B | 1.85%1.81B | -4.81%1.78B | 59.83%1.87B | |||
Net income from continuing operations | ---- | 72.00%-453M | ---- | ---- | -364.38%-1.62B | -38.74%612M | 0.91%999M | -24.43%990M | 27.56%1.31B | 23.59%1.03B |
Operating gains losses | ---- | 1,300.00%36M | ---- | ---- | -105.08%-3M | 637.50%59M | 111.11%8M | -4.35%-72M | 35.51%-69M | -664.29%-107M |
Depreciation and amortization | ---- | -21.29%1.26B | ---- | ---- | 21.09%1.6B | -9.51%1.32B | 8.86%1.46B | 23.32%1.34B | 6.24%1.09B | 5.02%1.03B |
Deferred tax | ---- | 37.17%-71M | ---- | ---- | -9.71%-113M | -148.58%-103M | -17.83%212M | 33.68%258M | -44.70%193M | 71.92%349M |
Other non cash items | ---- | 109.26%339M | ---- | ---- | 658.62%162M | -111.89%-29M | 7.96%244M | 201.33%226M | -81.57%75M | 24.46%407M |
Change In working capital | ---- | 210.49%1.26B | ---- | ---- | -8,900.00%-1.14B | 108.72%13M | 76.61%-149M | -27.40%-637M | 1.77%-500M | 24.70%-509M |
-Change in receivables | ---- | 177.71%265M | ---- | ---- | -301.18%-341M | -202.41%-85M | 175.45%83M | 24.66%-110M | 50.34%-146M | -18.07%-294M |
-Change in inventory | ---- | 144.93%257M | ---- | ---- | 1.55%-572M | -0.52%-581M | -186.14%-578M | 48.73%-202M | -173.61%-394M | -128.57%-144M |
-Change in payables and accrued expense | ---- | 588.46%358M | ---- | ---- | -76.26%52M | -43.41%219M | 209.32%387M | -213.83%-354M | 71.82%311M | -36.04%181M |
-Change in other current liabilities | ---- | 54.76%-38M | ---- | ---- | -354.55%-84M | -34.00%33M | --50M | ---- | ---- | ---- |
-Change in other working capital | ---- | 312.06%422M | ---- | ---- | -146.60%-199M | 569.23%427M | -413.79%-91M | 110.70%29M | -7.54%-271M | 61.05%-252M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 80.26%274M | 1,334.68%2.14B | --1.65B | --152M | -110.62%-173M | -35.13%1.63B | 38.50%2.51B | 1.85%1.81B | -4.81%1.78B | 59.83%1.87B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 57.13%-637M | 59.54%-1.49B | -189.67%-3.67B | -147.17%-1.27B | 65.50%-513M | 53.50%-1.49B | -192.32%-3.2B | |||
Capital expenditure reported | -6.80%96M | 21.83%-548M | ---392M | --103M | -6.86%-701M | 16.01%-656M | 3.94%-781M | -12.92%-813M | 4.38%-720M | -13.92%-753M |
Net PPE purchase and sale | ---- | 400.00%90M | ---- | ---- | -45.45%18M | 73.68%33M | -68.33%19M | 30.43%60M | -73.71%46M | 1,066.67%175M |
Net intangibles purchase and sale | ---- | 8.57%-96M | ---- | ---- | 1.87%-105M | 6.14%-107M | 17.39%-114M | -12.20%-138M | -16.04%-123M | -11.58%-106M |
Net business purchase and sale | ---- | 101.19%7M | ---- | ---- | 80.34%-588M | -855.59%-2.99B | -195.28%-313M | 81.00%-106M | 75.53%-558M | -1,057.36%-2.28B |
Net investment purchase and sale | ---- | 18.18%-90M | ---- | ---- | -329.17%-110M | 160.76%48M | -179.80%-79M | 175.00%99M | 43.59%-132M | -500.00%-234M |
Net other investing changes | ---- | 200.00%1M | ---- | ---- | -200.00%-1M | 0.00%1M | -99.74%1M | 38,500.00%386M | 200.00%1M | 99.13%-1M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---- | 57.23%-636M | ---- | ---- | 59.50%-1.49B | -189.82%-3.67B | -147.46%-1.27B | 65.55%-512M | 53.55%-1.49B | -192.95%-3.2B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -270.28%-848M | 121.21%498M | -586.13%-2.35B | 129.11%483M | -39.18%-1.66B | -2,307.41%-1.19B | 103.28%54M | |||
Net issuance payments of debt | ---- | -116.59%-181M | ---- | ---- | 534.66%1.09B | -132.06%-251M | 586.84%783M | -28.75%114M | 178.05%160M | 87.27%-205M |
Net common stock issuance | 294.74%148M | -278.29%-662M | ---497M | ---76M | 89.15%-175M | -443.10%-1.61B | 77.47%-297M | -39.03%-1.32B | -128.43%-948M | 21.10%-415M |
Cash dividends paid | ---- | 99.51%-2M | ---- | ---- | 14.52%-412M | -48,100.00%-482M | 99.78%-1M | -12.97%-453M | -4.43%-401M | -16.36%-384M |
Net other financing activities | ---- | 25.00%-3M | ---- | ---- | -300.00%-4M | 50.00%-1M | 33.33%-2M | 0.00%-3M | -100.28%-3M | 28.52%1.06B |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---- | -269.60%-848M | ---- | ---- | 121.30%500M | -585.92%-2.35B | 129.10%483M | -39.26%-1.66B | -2,267.27%-1.19B | 103.35%55M |
Net cash flow | ||||||||||
Beginning cash position | 88.23%1.81B | -49.11%1.17B | --1.16B | --960M | -28.61%2.3B | 126.39%3.23B | -15.58%1.43B | -12.94%1.69B | -16.92%1.94B | 32.16%2.33B |
Current changes in cash | -158.06%-209M | 166.21%776M | --581M | --360M | -18.62%-1.17B | -153.23%-988M | 811.11%1.86B | -3.98%-261M | -18.96%-251M | -136.07%-211M |
Effect of exchange rate changes | ---- | -292.68%-79M | ---- | ---- | -36.92%41M | 218.18%65M | -2,650.00%-55M | ---2M | --0 | -982.35%-184M |
End cash Position | 30.91%1.51B | 59.47%1.87B | --1.87B | --1.16B | -49.11%1.17B | -28.61%2.3B | 126.39%3.23B | -15.58%1.43B | -12.94%1.69B | -16.92%1.94B |
Free cash flow | 41.37%434M | 252.40%1.49B | --1.16B | --307M | -213.05%-979M | -46.41%866M | 87.47%1.62B | -8.00%862M | -7.32%937M | 144.20%1.01B |
Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion with Explanatory Notes |